Peri Tonsillar Infiltration of Ketamine or Bupivacaine for Post Tonsillectomy Analgesia
NCT ID: NCT05341323
Last Updated: 2022-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
80 participants
INTERVENTIONAL
2022-04-02
2022-07-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pre-emptive Trans-cutaneous Versus Trans-oral Ultrasound Guided Peritonsillar Infiltration With Bupivacaine During Tonsillectomy
NCT03361813
Evaluation of The Effect of Bupivacaine (Marcaine) in Reducing Early Post Tonsillectomy Pain
NCT01582022
Topical Ketamine Analgesia in Children Undergoing Tonsillectomy: a Clinical and Serum Level Assays Study.
NCT02720406
Bupivacaine in Tonsillectomy
NCT04825704
Dexamethasone-bupivacaine Versus Bupivacaine for Tonsillectomy Pain.
NCT03443778
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group K1 Ketamine
pre-incisional submucosal infiltration of ketamine .5 mg/kg in the Peritonsillar area
Ketamine.
Peritonsillar infiltration of ketamine
Group B1 Bupivacaine
pre-incisional submucosal infiltration of Bupivacaine .25 % in the Peritonsillar area
Bupivacaine
peritonsillar infiltration of Bupivacaine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ketamine.
Peritonsillar infiltration of ketamine
Bupivacaine
peritonsillar infiltration of Bupivacaine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* elective tonsillectomy or adenotonsillectomy with or without ventilation tube application.
Exclusion Criteria
* coagulopathy
* endocrine, neuropsychiatric or cardiopulmonary dysfunction
* increase intracranial pressure (ICP)
* psychiatric illness, history of seizure, patients under chronic analgesic treatment
* history of peritonsillar abscess, tonsillar malignancy.
3 Years
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Abdallah Abozaid
Resident doctor at otorhinolaryngiology, head and neck surgery department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ibrahem Risk, Professor
Role: STUDY_DIRECTOR
Professor of ENT
Osama Elshrief, Professor
Role: STUDY_CHAIR
Dean of Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag Faculty of Medicine
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soh_Med_22_02_07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.